FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:CBX5-GTSF1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: CBX5-GTSF1
FusionPDB ID: 13469
FusionGDB2.0 ID: 13469
HgeneTgene
Gene symbol

CBX5

GTSF1

Gene ID

23468

121355

Gene namechromobox 5gametocyte specific factor 1
SynonymsHEL25|HP1|HP1ACue110|FAM112B
Cytomap

12q13.13

12q13.13

Type of geneprotein-codingprotein-coding
Descriptionchromobox protein homolog 5HP1 alpha homologHP1-ALPHAHP1Hs alphaantigen p25chromobox homolog 5 (HP1 alpha homolog, Drosophila)epididymis luminal protein 25heterochromatin protein 1 homolog alphaheterochromatin protein 1-alphagametocyte-specific factor 1family with sequence similarity 112, member B
Modification date2020031320200320
UniProtAcc

P45973

Main function of 5'-partner protein: FUNCTION: Component of heterochromatin that recognizes and binds histone H3 tails methylated at 'Lys-9' (H3K9me), leading to epigenetic repression. In contrast, it is excluded from chromatin when 'Tyr-41' of histone H3 is phosphorylated (H3Y41ph). Can interact with lamin-B receptor (LBR). This interaction can contribute to the association of the heterochromatin with the inner nuclear membrane. Involved in the formation of functional kinetochore through interaction with MIS12 complex proteins. {ECO:0000269|PubMed:19783980}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000209875, ENST00000439541, 
ENST00000550411, 
ENST00000305879, 
ENST00000552395, ENST00000552397, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score13 X 10 X 9=11703 X 3 X 4=36
# samples 154
** MAII scorelog2(15/1170*10)=-2.96347412397489
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(4/36*10)=0.15200309344505
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
Fusion gene context

PubMed: CBX5 [Title/Abstract] AND GTSF1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: CBX5 [Title/Abstract] AND GTSF1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)CBX5(54645825)-GTSF1(54865061), # samples:2
Anticipated loss of major functional domain due to fusion event.CBX5-GTSF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
CBX5-GTSF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
CBX5-GTSF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
CBX5-GTSF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
CBX5-GTSF1 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF.
CBX5-GTSF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
CBX5-GTSF1 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneCBX5

GO:0045892

negative regulation of transcription, DNA-templated

9636147



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:54645825/chr12:54865061)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across CBX5 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across GTSF1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000550411CBX5chr1254645825-ENST00000552397GTSF1chr1254858951-13506423181034238
ENST00000550411CBX5chr1254645825-ENST00000305879GTSF1chr1254858951-13476423181034238

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000550411ENST00000552397CBX5chr1254645825-GTSF1chr1254858951-0.0082521370.99174786
ENST00000550411ENST00000305879CBX5chr1254645825-GTSF1chr1254858951-0.0087465780.99125344

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for CBX5-GTSF1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
CBX5chr1254645825GTSF1chr1254858951642108NSADDIKSKKKREPTPWTLRSYCNAP

Top

Potential FusionNeoAntigen Information of CBX5-GTSF1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CBX5-GTSF1_54645825_54858951.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CBX5-GTSF1chr1254645825chr1254858951642HLA-B48:01REPTPWTL0.99910.79491119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B40:01REPTPWTL0.9950.69011119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B13:01REPTPWTL0.99250.99011119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B47:01REPTPWTL0.93610.78031119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B39:13REPTPWTL0.90070.97311119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:02KREPTPWTL0.99760.54241019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:04KREPTPWTL0.99750.76091019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:05KREPTPWTL0.99740.8291019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:07KREPTPWTL0.99670.57791019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B39:24KREPTPWTL0.98780.68931019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B39:06KREPTPWTL0.98570.90021019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B39:01KREPTPWTL0.98160.90841019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B39:13KREPTPWTL0.96280.93611019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B14:02KREPTPWTL0.95650.9351019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B14:01KREPTPWTL0.95650.9351019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B38:01KREPTPWTL0.94890.96611019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B38:02KREPTPWTL0.94120.96561019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B48:01KREPTPWTL0.76740.73041019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B15:10KREPTPWTL0.59150.79381019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B15:18KREPTPWTL0.30420.91721019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B15:37KREPTPWTL0.21670.86451019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B47:01KREPTPWTL0.10440.74161019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B07:10KREPTPWTL0.02450.50521019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:02KKREPTPWTL0.99850.5448919
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:05KKREPTPWTL0.99820.7977919
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:04KKREPTPWTL0.9980.7567919
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:07KKREPTPWTL0.99370.5937919
CBX5-GTSF1chr1254645825chr1254858951642HLA-B35:01EPTPWTLRSY0.9690.82561222
CBX5-GTSF1chr1254645825chr1254858951642HLA-B35:08EPTPWTLRSY0.96080.69281222
CBX5-GTSF1chr1254645825chr1254858951642HLA-B35:05EPTPWTLRSY0.82860.53761222
CBX5-GTSF1chr1254645825chr1254858951642HLA-B48:01KKREPTPWTL0.80960.724919
CBX5-GTSF1chr1254645825chr1254858951642HLA-B38:01KKREPTPWTL0.64810.955919
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:02KKKREPTPWTL0.99990.5435819
CBX5-GTSF1chr1254645825chr1254858951642HLA-B57:01KSKKKREPTPW0.99970.9726617
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:07KKKREPTPWTL0.99970.6308819
CBX5-GTSF1chr1254645825chr1254858951642HLA-B58:02KSKKKREPTPW0.99910.9374617
CBX5-GTSF1chr1254645825chr1254858951642HLA-B58:01KSKKKREPTPW0.99730.954617
CBX5-GTSF1chr1254645825chr1254858951642HLA-B44:03REPTPWTLRSY0.9650.72821122
CBX5-GTSF1chr1254645825chr1254858951642HLA-B48:01KKKREPTPWTL0.96390.7199819
CBX5-GTSF1chr1254645825chr1254858951642HLA-B40:06REPTPWTL0.99910.90391119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B48:03REPTPWTL0.99630.74231119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B40:03REPTPWTL0.98820.63941119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B39:08REPTPWTL0.94830.92161119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B44:10REPTPWTL0.86050.61931119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:14KREPTPWTL0.99710.80321019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:95KREPTPWTL0.99490.75621019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:27KREPTPWTL0.99390.95591019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:05KREPTPWTL0.99120.95271019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:29KREPTPWTL0.98910.94061019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B39:12KREPTPWTL0.98120.91571019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B39:09KREPTPWTL0.98020.8351019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:13KREPTPWTL0.97740.92391019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:46KREPTPWTL0.94650.91591019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:67KREPTPWTL0.90640.94861019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:80KREPTPWTL0.90640.94861019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B39:05KREPTPWTL0.90210.89131019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:03KREPTPWTL0.89710.84131019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C04:10KREPTPWTL0.89620.91741019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:10KREPTPWTL0.890.96511019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:19KREPTPWTL0.88630.84161019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C04:07KREPTPWTL0.88580.91571019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B73:01KREPTPWTL0.71490.88871019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B39:08KREPTPWTL0.56890.78331019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B48:03KREPTPWTL0.4560.64821019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B14:03KREPTPWTL0.41210.90221019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C04:14KREPTPWTL0.3990.9511019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C12:16KREPTPWTL0.06940.96281019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:14KREPTPWTLR0.99910.55891020
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:19KKREPTPWTL0.99180.8321919
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:95KKREPTPWTL0.98770.697919
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:05KKREPTPWTL0.98420.9432919
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:27KKREPTPWTL0.97410.9501919
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:03KKREPTPWTL0.94110.8118919
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:95KKKREPTPWTL0.99620.657819
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:03KKKREPTPWTL0.99380.7707819
CBX5-GTSF1chr1254645825chr1254858951642HLA-B40:04REPTPWTL0.99740.88561119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B40:12REPTPWTL0.99630.74231119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B40:36REPTPWTL0.9950.63761119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B40:49REPTPWTL0.9940.70491119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B39:02REPTPWTL0.92630.96881119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B41:03REPTPWTL0.81540.74391119
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:06KREPTPWTL0.99820.77991019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:08KREPTPWTL0.99750.74181019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:09KREPTPWTL0.99740.83771019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:10KREPTPWTL0.99740.85311019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:01KREPTPWTL0.99620.76141019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B39:02KREPTPWTL0.98540.93531019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:17KREPTPWTL0.98320.96371019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B39:31KREPTPWTL0.9760.91071019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B38:05KREPTPWTL0.94890.96611019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:02KREPTPWTL0.90640.94861019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C18:01KREPTPWTL0.89810.90641019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C04:01KREPTPWTL0.88580.91571019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C06:08KREPTPWTL0.78120.99261019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:04KREPTPWTL0.75490.92881019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C06:06KREPTPWTL0.67020.98491019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:22KREPTPWTL0.65120.70041019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B39:11KREPTPWTL0.60190.72071019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B15:09KREPTPWTL0.51370.881019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B40:12KREPTPWTL0.4560.64821019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C03:67KREPTPWTL0.44580.98261019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C04:04KREPTPWTL0.40140.97711019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C06:17KREPTPWTL0.08660.9931019
CBX5-GTSF1chr1254645825chr1254858951642HLA-C06:02KREPTPWTL0.08660.9931019
CBX5-GTSF1chr1254645825chr1254858951642HLA-B15:68KKKREPTPW0.0030.6235817
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:10KREPTPWTLR0.99880.59751020
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:10KKREPTPWTL0.99820.8465919
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:06KKREPTPWTL0.9980.7748919
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:08KKREPTPWTL0.99780.7099919
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:09KKREPTPWTL0.99450.7865919
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:01KKREPTPWTL0.99070.7112919
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:22KKREPTPWTL0.98160.6934919
CBX5-GTSF1chr1254645825chr1254858951642HLA-B35:77EPTPWTLRSY0.9690.82561222
CBX5-GTSF1chr1254645825chr1254858951642HLA-B35:23EPTPWTLRSY0.96770.82191222
CBX5-GTSF1chr1254645825chr1254858951642HLA-B35:24EPTPWTLRSY0.9240.86561222
CBX5-GTSF1chr1254645825chr1254858951642HLA-B15:68KKREPTPWTL0.92370.7334919
CBX5-GTSF1chr1254645825chr1254858951642HLA-B35:30EPTPWTLRSY0.9040.69871222
CBX5-GTSF1chr1254645825chr1254858951642HLA-B35:17EPTPWTLRSY0.9040.69871222
CBX5-GTSF1chr1254645825chr1254858951642HLA-B35:11EPTPWTLRSY0.89910.90681222
CBX5-GTSF1chr1254645825chr1254858951642HLA-B15:08EPTPWTLRSY0.77830.81371222
CBX5-GTSF1chr1254645825chr1254858951642HLA-B15:11EPTPWTLRSY0.77080.79181222
CBX5-GTSF1chr1254645825chr1254858951642HLA-B35:43EPTPWTLRSY0.76670.81561222
CBX5-GTSF1chr1254645825chr1254858951642HLA-B38:05KKREPTPWTL0.64810.955919
CBX5-GTSF1chr1254645825chr1254858951642HLA-A25:01EPTPWTLRSY0.45790.73681222
CBX5-GTSF1chr1254645825chr1254858951642HLA-B18:07EPTPWTLRSY0.28130.77061222
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:06KKKREPTPWTL0.99980.79819
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:08KKKREPTPWTL0.99980.6727819
CBX5-GTSF1chr1254645825chr1254858951642HLA-B57:10KSKKKREPTPW0.99970.9726617
CBX5-GTSF1chr1254645825chr1254858951642HLA-B27:09KKKREPTPWTL0.99970.7558819
CBX5-GTSF1chr1254645825chr1254858951642HLA-B57:04KSKKKREPTPW0.99930.7575617
CBX5-GTSF1chr1254645825chr1254858951642HLA-B58:06KSKKKREPTPW0.99870.9185617
CBX5-GTSF1chr1254645825chr1254858951642HLA-C07:01KKKREPTPWTL0.9970.6888819
CBX5-GTSF1chr1254645825chr1254858951642HLA-B15:53REPTPWTLRSY0.99650.7181122
CBX5-GTSF1chr1254645825chr1254858951642HLA-B44:13REPTPWTLRSY0.9650.72821122
CBX5-GTSF1chr1254645825chr1254858951642HLA-B44:26REPTPWTLRSY0.9650.72821122
CBX5-GTSF1chr1254645825chr1254858951642HLA-B44:07REPTPWTLRSY0.9650.72821122

Top

Potential FusionNeoAntigen Information of CBX5-GTSF1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CBX5-GTSF1_54645825_54858951.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1103SADDIKSKKKREPTP116
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1103ADDIKSKKKREPTPW217
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1111SADDIKSKKKREPTP116
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1141SADDIKSKKKREPTP116
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1141ADDIKSKKKREPTPW217
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1155SADDIKSKKKREPTP116
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1155ADDIKSKKKREPTPW217
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1155NSADDIKSKKKREPT015
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1155DDIKSKKKREPTPWT318
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1159SADDIKSKKKREPTP116
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1159ADDIKSKKKREPTPW217
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1163SADDIKSKKKREPTP116
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1163ADDIKSKKKREPTPW217
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1170SADDIKSKKKREPTP116
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1170ADDIKSKKKREPTPW217
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1176SADDIKSKKKREPTP116
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1176ADDIKSKKKREPTPW217
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1185SADDIKSKKKREPTP116
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1185ADDIKSKKKREPTPW217
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1324SADDIKSKKKREPTP116
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1324ADDIKSKKKREPTPW217
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1363SADDIKSKKKREPTP116
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1375SADDIKSKKKREPTP116
CBX5-GTSF1chr1254645825chr1254858951642DRB1-1375ADDIKSKKKREPTPW217

Top

Fusion breakpoint peptide structures of CBX5-GTSF1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
4602KSKKKREPTPWTLRCBX5GTSF1chr1254645825chr1254858951642

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of CBX5-GTSF1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN4602KSKKKREPTPWTLR-7.15543-7.26883
HLA-B14:023BVN4602KSKKKREPTPWTLR-4.77435-5.80965
HLA-B52:013W394602KSKKKREPTPWTLR-6.80875-6.92215
HLA-B52:013W394602KSKKKREPTPWTLR-4.20386-5.23916
HLA-A11:014UQ24602KSKKKREPTPWTLR-7.5194-8.5547
HLA-A11:014UQ24602KSKKKREPTPWTLR-6.9601-7.0735
HLA-A24:025HGA4602KSKKKREPTPWTLR-7.52403-7.63743
HLA-A24:025HGA4602KSKKKREPTPWTLR-5.82433-6.85963
HLA-B27:056PYJ4602KSKKKREPTPWTLR-3.28285-4.31815
HLA-B44:053DX84602KSKKKREPTPWTLR-5.91172-6.94702
HLA-B44:053DX84602KSKKKREPTPWTLR-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of CBX5-GTSF1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
CBX5-GTSF1chr1254645825chr12548589511019KREPTPWTLAAGAGAGAGCCGACTCCCTGGACCCTG
CBX5-GTSF1chr1254645825chr12548589511020KREPTPWTLRAAGAGAGAGCCGACTCCCTGGACCCTGAGA
CBX5-GTSF1chr1254645825chr12548589511119REPTPWTLAGAGAGCCGACTCCCTGGACCCTG
CBX5-GTSF1chr1254645825chr12548589511122REPTPWTLRSYAGAGAGCCGACTCCCTGGACCCTGAGAAGCTAT
CBX5-GTSF1chr1254645825chr12548589511222EPTPWTLRSYGAGCCGACTCCCTGGACCCTGAGAAGCTAT
CBX5-GTSF1chr1254645825chr1254858951617KSKKKREPTPWAAATCTAAAAAAAAGAGAGAGCCGACTCCCTGG
CBX5-GTSF1chr1254645825chr1254858951817KKKREPTPWAAAAAAAAGAGAGAGCCGACTCCCTGG
CBX5-GTSF1chr1254645825chr1254858951819KKKREPTPWTLAAAAAAAAGAGAGAGCCGACTCCCTGGACCCTG
CBX5-GTSF1chr1254645825chr1254858951919KKREPTPWTLAAAAAGAGAGAGCCGACTCCCTGGACCCTG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
CBX5-GTSF1chr1254645825chr1254858951015NSADDIKSKKKREPTAACAGTGCCGATGACATCAAATCTAAAAAAAAGAGAGAGCCGACT
CBX5-GTSF1chr1254645825chr1254858951116SADDIKSKKKREPTPAGTGCCGATGACATCAAATCTAAAAAAAAGAGAGAGCCGACTCCC
CBX5-GTSF1chr1254645825chr1254858951217ADDIKSKKKREPTPWGCCGATGACATCAAATCTAAAAAAAAGAGAGAGCCGACTCCCTGG
CBX5-GTSF1chr1254645825chr1254858951318DDIKSKKKREPTPWTGATGACATCAAATCTAAAAAAAAGAGAGAGCCGACTCCCTGGACC

Top

Information of the samples that have these potential fusion neoantigens of CBX5-GTSF1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
OVCBX5-GTSF1chr1254645825ENST00000550411chr1254858951ENST00000305879TCGA-25-1329-01A

Top

Potential target of CAR-T therapy development for CBX5-GTSF1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to CBX5-GTSF1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to CBX5-GTSF1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource